serosep uk limited Company Information
Company Number
08096199
Website
www.serosep.comRegistered Address
2-3 baird close, crawley, west sussex, RH109SY
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Telephone
01293889215
Next Accounts Due
20 days late
Group Structure
View All
Shareholders
serosep holdings limited 100%
serosep uk limited Estimated Valuation
The estimated valuation range for serosep uk limited, derived from financial data as of June 2022 and the most recent industry multiples, is between £6.7m to £9.6m
serosep uk limited Estimated Valuation
The estimated valuation range for serosep uk limited, derived from financial data as of June 2022 and the most recent industry multiples, is between £6.7m to £9.6m
serosep uk limited Estimated Valuation
The estimated valuation range for serosep uk limited, derived from financial data as of June 2022 and the most recent industry multiples, is between £6.7m to £9.6m
Get a detailed valuation report, edit figures and unlock valuation multiples.
Serosep Uk Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Serosep Uk Limited Overview
Serosep Uk Limited is a live company located in west sussex, RH109SY with a Companies House number of 08096199. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in June 2012, it's largest shareholder is serosep holdings limited with a 100% stake. Serosep Uk Limited is a established, mid sized company, Pomanda has estimated its turnover at £10.8m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Serosep Uk Limited Health Check
Pomanda's financial health check has awarded Serosep Uk Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 2 areas for improvement. Company Health Check FAQs
6 Strong
4 Regular
2 Weak
Size
annual sales of £10.8m, make it larger than the average company (£1.6m)
- Serosep Uk Limited
£1.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 49%, show it is growing at a faster rate (3.3%)
- Serosep Uk Limited
3.3% - Industry AVG
Production
with a gross margin of 44.5%, this company has a comparable cost of product (44.5%)
- Serosep Uk Limited
44.5% - Industry AVG
Profitability
an operating margin of 10.1% make it more profitable than the average company (5.9%)
- Serosep Uk Limited
5.9% - Industry AVG
Employees
with 98 employees, this is above the industry average (16)
- Serosep Uk Limited
16 - Industry AVG
Pay Structure
on an average salary of £46.5k, the company has an equivalent pay structure (£46.5k)
- Serosep Uk Limited
£46.5k - Industry AVG
Efficiency
resulting in sales per employee of £110.3k, this is equally as efficient (£110.9k)
- Serosep Uk Limited
£110.9k - Industry AVG
Debtor Days
it gets paid by customers after 65 days, this is near the average (59 days)
- Serosep Uk Limited
59 days - Industry AVG
Creditor Days
its suppliers are paid after 92 days, this is slower than average (33 days)
- Serosep Uk Limited
33 days - Industry AVG
Stock Days
it holds stock equivalent to 65 days, this is more than average (32 days)
- Serosep Uk Limited
32 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 22 weeks, this is less cash available to meet short term requirements (32 weeks)
22 weeks - Serosep Uk Limited
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 37.4%, this is a lower level of debt than the average (53.4%)
37.4% - Serosep Uk Limited
53.4% - Industry AVG
serosep uk limited Credit Report and Business Information
Serosep Uk Limited Competitor Analysis
Perform a competitor analysis for serosep uk limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
serosep uk limited Ownership
SEROSEP UK LIMITED group structure
Serosep Uk Limited has no subsidiary companies.
Ultimate parent company
SCANLON INVESTMENTS LIMITED
IE510481
1 parent
SEROSEP UK LIMITED
08096199
serosep uk limited directors
Serosep Uk Limited currently has 3 directors. The longest serving directors include Mrs Noreen Scanlon (Jun 2012) and Mr Dermot Scanlon (Jun 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mrs Noreen Scanlon | Ireland | 59 years | Jun 2012 | - | Director |
Mr Dermot Scanlon | Ireland | 60 years | Jun 2012 | - | Director |
Mr Allin Winter | England | 53 years | Jun 2012 | - | Director |
SEROSEP UK LIMITED financials
Serosep Uk Limited's latest turnover from June 2022 is estimated at £10.8 million and the company has net assets of £4.2 million. According to their latest financial statements, we estimate that Serosep Uk Limited has 98 employees and maintains cash reserves of £1.1 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||
Other Income Or Grants | ||||||||||
Cost Of Sales | ||||||||||
Gross Profit | ||||||||||
Admin Expenses | ||||||||||
Operating Profit | ||||||||||
Interest Payable | ||||||||||
Interest Receivable | ||||||||||
Pre-Tax Profit | ||||||||||
Tax | ||||||||||
Profit After Tax | ||||||||||
Dividends Paid | ||||||||||
Retained Profit | ||||||||||
Employee Costs | ||||||||||
Number Of Employees | 13 | 11 | 7 | 5 | 3 | |||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 2,541,687 | 496,181 | 439,735 | 593,762 | 507,957 | 204,635 | 146,756 | 36,144 | 0 | 29,236 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34,688 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117,994 | 52,646 | 117,426 |
Total Fixed Assets | 2,541,687 | 496,181 | 439,735 | 593,762 | 507,957 | 204,635 | 146,756 | 154,138 | 87,334 | 146,662 |
Stock & work in progress | 1,081,246 | 1,482,092 | 176,028 | 61,711 | 66,874 | 29,761 | 99,018 | 41,101 | 26,169 | 20,781 |
Trade Debtors | 1,944,731 | 1,247,376 | 753,162 | 594,657 | 377,315 | 235,424 | 93,424 | 0 | 0 | 0 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 31,162 | 106,196 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash | 1,107,844 | 2,074,046 | 834,176 | 641,169 | 1,022,439 | 366,574 | 366,643 | 82,244 | 87,412 | 15,064 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 4,164,983 | 4,909,710 | 1,763,366 | 1,297,537 | 1,466,628 | 631,759 | 559,085 | 123,345 | 113,581 | 35,845 |
total assets | 6,706,670 | 5,405,891 | 2,203,101 | 1,891,299 | 1,974,585 | 836,394 | 705,841 | 277,483 | 200,915 | 182,507 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 1,524,993 | 560,545 | 1,411,403 | 1,125,980 | 972,335 | 203,412 | 198,689 | 370,229 | 55,826 | 24,759 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 98,201 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 982,535 | 1,371,491 | 0 | 0 | 247,517 | 77,511 | 35,951 | 0 | 0 | 0 |
total current liabilities | 2,507,528 | 2,030,237 | 1,411,403 | 1,125,980 | 1,219,852 | 280,923 | 234,640 | 370,229 | 55,826 | 24,759 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250,000 | 250,000 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 74,315 | 68,554 | 352,740 | 644,653 | 529,809 | 519,464 | 0 | 0 | 0 |
provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 0 | 74,315 | 68,554 | 352,740 | 644,653 | 529,809 | 519,464 | 0 | 250,000 | 250,000 |
total liabilities | 2,507,528 | 2,104,552 | 1,479,957 | 1,478,720 | 1,864,505 | 810,732 | 754,104 | 370,229 | 305,826 | 274,759 |
net assets | 4,199,142 | 3,301,339 | 723,144 | 412,579 | 110,080 | 25,662 | -48,263 | -92,746 | -104,911 | -92,252 |
total shareholders funds | 4,199,142 | 3,301,339 | 723,144 | 412,579 | 110,080 | 25,662 | -48,263 | -92,746 | -104,911 | -92,252 |
Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||
Operating Profit | ||||||||||
Depreciation | 229,521 | 206,747 | 205,115 | 145,952 | 0 | 45,231 | 26,964 | 0 | 7,548 | 4,247 |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax | ||||||||||
Stock | -400,846 | 1,306,064 | 114,317 | -5,163 | 37,113 | -69,257 | 57,917 | 14,932 | 5,388 | 20,781 |
Debtors | 622,321 | 600,410 | 158,505 | 217,342 | 141,891 | 142,000 | -24,570 | 65,348 | -64,780 | 117,426 |
Creditors | 964,448 | -850,858 | 285,423 | 153,645 | 768,923 | 4,723 | -171,540 | 314,403 | 31,067 | 24,759 |
Accruals and Deferred Income | -388,956 | 1,371,491 | 0 | -247,517 | 170,006 | 41,560 | 35,951 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | ||||||||||
Investing Activities | ||||||||||
capital expenditure | ||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -34,688 | 34,688 | 0 |
cash flow from investments | ||||||||||
Financing Activities | ||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -250,000 | 0 | 250,000 |
Hire Purchase and Lease Commitments | -98,201 | 98,201 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | -74,315 | 5,761 | -284,186 | -291,913 | 114,844 | 10,345 | 519,464 | 0 | 0 | 0 |
share issue | ||||||||||
interest | ||||||||||
cash flow from financing | ||||||||||
cash and cash equivalents | ||||||||||
cash | -966,202 | 1,239,870 | 193,007 | -381,270 | 655,865 | -69 | 284,399 | -5,168 | 72,348 | 15,064 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -966,202 | 1,239,870 | 193,007 | -381,270 | 655,865 | -69 | 284,399 | -5,168 | 72,348 | 15,064 |
P&L
June 2022turnover
10.8m
+56%
operating profit
1.1m
0%
gross margin
44.6%
-0.66%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2022net assets
4.2m
+0.27%
total assets
6.7m
+0.24%
cash
1.1m
-0.47%
net assets
Total assets minus all liabilities
serosep uk limited company details
company number
08096199
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
June 2012
age
12
accounts
Small Company
ultimate parent company
previous names
N/A
incorporated
UK
address
2-3 baird close, crawley, west sussex, RH109SY
last accounts submitted
June 2022
serosep uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to serosep uk limited.
serosep uk limited Companies House Filings - See Documents
date | description | view/download |
---|